Free Trial

Oramed Pharmaceuticals (ORMP) Earnings Date, Estimates & Call Transcripts

$2.30
-0.01 (-0.43%)
(As of 05/22/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 8Estimated
Actual EPS
(Mar. 6)
-$0.08 Beat By $0.04
Consensus EPS
(Mar. 6)
-$0.12
Skip Charts & View Estimated and Actual Earnings Data

ORMP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ORMP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Oramed Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241$0.02$0.02$0.02
Q2 20241($0.02)($0.02)($0.02)
Q3 20241($0.04)($0.04)($0.04)
Q4 20241($0.09)($0.09)($0.09)
FY 20244($0.13)($0.13)($0.13)
Q1 20251($0.07)($0.07)($0.07)
Q2 20251($0.08)($0.08)($0.08)
Q3 20251($0.09)($0.09)($0.09)
Q4 20251($0.11)($0.11)($0.11)
FY 20254($0.35)($0.35)($0.35)

ORMP Earnings Date and Information

Oramed Pharmaceuticals last released its earnings data on March 6th, 2024. The biotechnology company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.12) by $0.04. Oramed Pharmaceuticals has generated $0.26 earnings per share over the last year ($0.26 diluted earnings per share) and currently has a price-to-earnings ratio of 8.8. Earnings for Oramed Pharmaceuticals are expected to decrease in the coming year, from ($0.25) to ($0.36) per share. Oramed Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.

Oramed Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/8/2024
(Estimated)
------- 
3/6/2024Q4 2023($0.12)($0.08)+$0.04($0.49)--
11/9/2023Q3 2023($0.09)($0.08)+$0.01($0.08)--
8/10/2023Q2 2023($0.11)($0.03)+$0.08($0.03)$0.70 million$0.67 million
5/11/2023Q1 2023($0.23)($0.08)+$0.15($0.08)$0.75 million$0.67 million
3/6/2023Q4 2022($0.22)($0.22)-($0.22)$0.75 million$0.68 million
11/10/2022Q3 2022($0.26)($0.18)+$0.08($0.18)$0.70 million$0.68 million
8/10/2022Q2 2022-$0.27+$0.27$0.27-$0.67 million
5/12/2022Q1 2022-($0.27)($0.27)($0.27)-$0.67 million
1/10/2022Q1($0.1650)($0.22)($0.0550)($0.22)$0.70 million$0.67 million
11/24/2021Q4 2021($0.10)($0.21)($0.11)($0.21)$0.80 million$0.68 million
7/13/2021Q3($0.20)($0.17)+$0.03($0.17)$0.70 million$0.68 million
4/12/2021Q2($0.1750)($0.17)+$0.0050($0.17)-$0.67 million
1/13/2021Q1($0.1450)($0.23)($0.0850)($0.23)-$0.67 million
11/23/2020Q4($0.2070)($0.12)+$0.0870($0.12)$0.69 million$0.68 million
7/7/2020Q3($0.1680)($0.10)+$0.0680($0.10)$0.69 million$0.68 million
4/6/2020Q2 2020($0.25)($0.21)+$0.04($0.21)-$0.67 million
1/9/2020Q1($0.26)($0.15)+$0.11($0.15)-$0.67 million
11/27/2019Q4 2019($0.34)$0.13+$0.47$0.13$0.65 million$0.68 million
7/10/2019Q3 2019($0.23)($0.23)-($0.23)$0.71 million$0.68 million

Oramed Pharmaceuticals Earnings - Frequently Asked Questions

When is Oramed Pharmaceuticals's earnings date?

Oramed Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on ORMP's earnings history.

Did Oramed Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Oramed Pharmaceuticals (NASDAQ:ORMP) reported ($0.08) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.12) by $0.04. Learn more on analysts' earnings estimate vs. ORMP's actual earnings.

How much revenue does Oramed Pharmaceuticals generate each year?

Oramed Pharmaceuticals (NASDAQ:ORMP) has a recorded annual revenue of $1.34 million.

How much profit does Oramed Pharmaceuticals generate each year?

Oramed Pharmaceuticals (NASDAQ:ORMP) has a recorded net income of $5.53 million. ORMP has generated $0.26 earnings per share over the last four quarters.

What is Oramed Pharmaceuticals's price-to-earnings ratio?

Oramed Pharmaceuticals (NASDAQ:ORMP) has a trailing price-to-earnings ratio of 8.85.

What is Oramed Pharmaceuticals's EPS forecast for next year?

Oramed Pharmaceuticals's earnings are expected to decrease from ($0.25) per share to ($0.36) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ORMP) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners